SCHEMBL257243

SCHEMBL257243

CCCCOc1cc(C(=O)c2ccccc2F)ccc1C(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
KMT2A Q03164 2/20 0.48
L3MBTL1 Q9Y468 3/20 0.46
MAPT P10636 3/20 0.46
HPGD P15428 2/20 0.46
HSP90AA1 P07900 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
PDE4D Q08499 1/20 0.45
POLB P06746 1/20 0.45
CCNB2 O95067 1/20 0.44
CCNE2 O96020 1/20 0.44
CDK1 P06493 1/20 0.44
CDK4 P11802 1/20 0.44
CCNB1 P14635 1/20 0.44
CCND1 P24385 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257257 0.88 LMNA (0.54) ALDH1A1KMT2AL3MBTL1KDM4EPOLB
SCHEMBL1688009 0.79 FAAH (0.52) KMT2ACCNB2CCNE2CDK1CDK4
SCHEMBL10047545 0.79 ALDH1A1 (0.55) ALDH1A1KMT2AL3MBTL1MAPTHPGD
SCHEMBL7956581 0.79 MAPT (0.62) ALDH1A1KMT2AL3MBTL1MAPTHPGD
SCHEMBL257352 0.78 LMNA (0.54) ALDH1A1KMT2AL3MBTL1MAPTHPGD
Benzene SCHEMBL28006415 0.78 MAPT (0.60) ALDH1A1KMT2AL3MBTL1MAPTHPGD
SCHEMBL10047113 0.77 KMT2A (0.51) ALDH1A1KMT2AL3MBTL1MAPTHPGD
SCHEMBL257672 0.77 ALDH1A1 (0.47) ALDH1A1KMT2AL3MBTL1MAPTHPGD
SCHEMBL257355 0.77 PDE5A (0.55) ALDH1A1KMT2APDE4DPOLBPYGL
SCHEMBL15100957 0.77 KMT2A (0.43) ALDH1A1KMT2AL3MBTL1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 ALDH1A1 538/4885KMT2A 1199/4885L3MBTL1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.